Assessment of Endogenous Oxalate Synthesis

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

February 10, 2022

Primary Completion Date

September 9, 2024

Study Completion Date

September 9, 2024

Conditions
HealthyKidney StoneObesity
Interventions
DIETARY_SUPPLEMENT

Low-oxalate controlled diet

Participants will consume a diet that is controlled in its contents of protein, carbohydrates, fat, calcium, oxalate, vitamin C and sodium for 5 days. Participants will be asked not to take any dietary supplements, exercise strenuously, or consume food or drink that is not provided to them.

OTHER

Primed, continuous intravenous infusion of 13C2-oxalate

Participants will receive a continuous intravenous administration of carbon-13 oxalate, a naturally occurring form of oxalate, over the course of several hours until steady-state is achieved, using an IV catheter, while remaining fasting.

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER